- Home
- OPRA vs ARVN Comparison
OPRA vs ARVN Comparison
Compare OPRA & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPRA
- ARVN
- Stock Information
- Founded
- OPRA 1996
- ARVN 2015
- Country
- OPRA Norway
- ARVN United States
- Employees
- OPRA N/A
- ARVN N/A
- Industry
- OPRA Computer Software: Prepackaged Software
- ARVN Biotechnology: Pharmaceutical Preparations
- Sector
- OPRA Technology
- ARVN Health Care
- Exchange
- OPRA Nasdaq
- ARVN Nasdaq
- Market Cap
- OPRA 1.8B
- ARVN 1.8B
- IPO Year
- OPRA 2018
- ARVN 2018
- Fundamental
- Price
- OPRA $18.80
- ARVN $18.48
- Analyst Decision
- OPRA Strong Buy
- ARVN Strong Buy
- Analyst Count
- OPRA 4
- ARVN 13
- Target Price
- OPRA $24.75
- ARVN $63.00
- AVG Volume (30 Days)
- OPRA 583.3K
- ARVN 967.8K
- Earning Date
- OPRA 10-29-2024
- ARVN 10-30-2024
- Dividend Yield
- OPRA 4.25%
- ARVN N/A
- EPS Growth
- OPRA 142.24
- ARVN N/A
- EPS
- OPRA 1.78
- ARVN N/A
- Revenue
- OPRA $447,818,000.00
- ARVN $161,100,000.00
- Revenue This Year
- OPRA $21.42
- ARVN $237.44
- Revenue Next Year
- OPRA $15.51
- ARVN N/A
- P/E Ratio
- OPRA $10.59
- ARVN N/A
- Revenue Growth
- OPRA 17.82
- ARVN 1.07
- 52 Week Low
- OPRA $10.11
- ARVN $17.37
- 52 Week High
- OPRA $20.70
- ARVN $53.08
- Technical
- Relative Strength Index (RSI)
- OPRA 48.47
- ARVN 32.78
- Support Level
- OPRA $18.29
- ARVN $17.37
- Resistance Level
- OPRA $20.60
- ARVN $19.21
- Average True Range (ATR)
- OPRA 0.94
- ARVN 1.64
- MACD
- OPRA -0.19
- ARVN -0.59
- Stochastic Oscillator
- OPRA 35.02
- ARVN 11.80
About OPRA Opera Limited
Opera Ltd is a world-wide internet brand with a large, engaged and growing base. It offers users products and services that include a variety of PC and mobile browsers, Opera Gaming portals and development tools, Opera News content recommendation products, and a number of e-commerce products and services. Its features include tabbed browsing, data savings, PC/mobile sync, and numerous features focused on privacy and security, including ad blocking and a built-in VPN. Its browser products include Opera Mini, Opera Browser for Android and iOS, Opera for Computers, Opera GX and Opera GX Mobile, separate browsers tailored for gamers. The newest addition of browsers is the beta release of a Web3-centric browser for PC and mobile which is tailored for crypto enthusiasts.
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.